Please provide your email address to receive an email when new articles are posted on . Mortality, sedation quality and delirium in those receiving dexmedetomidine or clonidine did not differ from ...
MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results